Lansen Pharmaceutical Holdings Ltd ($503) - buy or sell? Stock discussion, ideas, forum

Lansen Pharmaceutical Holdings Ltd

Lansen Pharmaceutical holdings Ltd.

Industry: Pharmaceuticals

Ticker	Exchange	ISIN	Name
$503	HKEx Main Board	KYG5380M1033	Code: 503

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 503 stock

Share your investment idea or question on Lansen Pharmaceutical Holdings Ltd stock:

Latest twits on Lansen Pharmaceutical Holdings Ltd (503)

No twits yet. Be the first to post!

Have a question about 503? Ask and other investors will be eager to help you.

Have an idea about 503? Share it with other investors.

Lansen Pharmaceutical Holdings Ltd news

30/03/2016 Lansen Pharmaceutical Holdings Ltd Net Income dropped on 85.2% in 2015 and EBITDA Margin decreased on 2.0 pp from 19.2% to 17.2%

Lansen Pharmaceutical Holdings Ltd stock price chart

Lansen Pharmaceutical Holdings Ltd financials

mln. $	FY2010	FY2011	FY2012

Revenue	58.607	74.475	93.844
EBITDA	13.371	14.847	17.808
Net income	10.213	12.453	13.998
CAPEX	3.368	3.192	7.767
Debt	10.878	29.015	42.255
Cash	14.827	15.592	11.381

Lansen Pharmaceutical Holdings Ltd news

30/03/2016 Lansen Pharmaceutical Holdings Ltd Net Income dropped on 85.2% in 2015 and EBITDA Margin decreased on 2.0 pp from 19.2% to 17.2%

About Lansen Pharmaceutical Holdings Ltd

Lansen Pharmaceutical holdings Ltd. is a pharmaceutical holding company. The Company's subsidiaries produce and sell rheumatic specialty prescription western pharmaceuticals in the Peoples Republic of China.